KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Cell Therapy Catapult & partners launch UK cell therapy database of research funding

Cell Therapy Catapult & partners launch UK cell therapy database of research funding

Over 100 sources identified, providing searchable resource for researchers

London, UK, November 20 2014 - The Cell Therapy Catapult, which is focused on the development of the UK cell therapy industry to increase the nation's health and wealth, has collaborated with the UK Regenerative Medicine Platform, the Knowledge Transfer Network and the Association of Medical Research Charities to develop a database of UK cell therapy research funding. The database, which is launched today1, has identified over 100 sources of funding from 34 organisations, totalling over £3bn for which cell therapies are believed to be eligible; of this around £100m is earmarked specifically for the sector. Fully searchable, it is designed to help researchers identify quickly and accurately appropriate sources of funding for their work, as well as provide an up-to-date snapshot of the UK environment. 

Data was collected in the first half of 2014 from the research councils, medical research charities, other UK Government-funded organisations (such as the UK's innovation agency, Innovate UK2 and the National Institute for Health Research) and EU bodies3. With each funding scheme categorised by research stage, eligibility criteria, therapeutic area and closing date, the database lists schemes open for submission as of July 2014 and will be updated regularly. Grants in the database cover a broad size range, with the smallest at £5,000 and the largest a €20m Horizon 2020 call, with the majority not exceeding £1m. 
 
Reflecting the importance of medical charities in catalysing and supporting early research in specialised areas, they are responsible for 65% of grant schemes (7% of the total funding available by value). Also significant, the European Union contributes 55% of the funding and 13% of the schemes. In line with the picture seen in the Cell Therapy Catapult UK cell therapy clinical trials and preclinical research databases, there are a large number of funding schemes for oncology, neurology, ophthalmology and cardiovascular research. 
 

Keith Thompson, CEO of the Cell Therapy Catapult, said: 'With our partners, we are delighted to launch this database, which we hope will enable researchers developing the therapies and technologies of the future to identify suitable funding sources quickly and accurately. Information will be updated regularly, with inclusion of data from the US and more EU organisations planned. We'd like to thank the funding organisations for their input, and look forward to feedback and comments from the community.'